BioCorRx (BICX) Research & Development (2017 - 2026)
BioCorRx's (BICX) quarterly Research & Development came in at $352333.0 in Q1 2026, up 117.6% year-on-year from $161919.0 in Q1 2025, and down 80.08% quarter-over-quarter from $1.8 million in Q4 2025.
BioCorRx (BICX) Research & Development (2017 - 2026) Analysis & Trends
BioCorRx has disclosed Research & Development across 10 years of filings, most recently posting $352333.0 for Q1 2026.
- Research & Development for Q1 2026 came in at $352333.0, up 117.6% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.4 million (up 139.2% YoY), and the FY2025 annual result was $1.8 million, up 19.29% from the prior year.
- Research & Development came in at $352333.0 for Q1 2026 at BioCorRx, down from $1.8 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $1.8 million in Q4 2025 to a low of $128295.0 in Q4 2023.
- The 5-year median for Research & Development is $296860.0 (2025), against an average of $436360.3.
- Across the five-year window, Research & Development slumped 76.07% in 2023 and surged 549.06% in 2025, its largest moves.
- BioCorRx's Research & Development stood at $536104.0 in 2022, then plunged by 76.07% to $128295.0 in 2023, then soared by 112.43% to $272543.0 in 2024, then soared by 549.06% to $1.8 million in 2025, then plunged by 80.08% to $352333.0 in 2026.
- The last three Research & Development figures came in at $352333.0 (Q1 2026), $1.8 million (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 83.85 Bn | 86.23 Bn | 16.26 Bn | - |
| 2 | Tenet Healthcare | 14.98 Bn | 14.15 Bn | 4.41 Bn | - |
| 3 | Davita | 13.99 Bn | 14.84 Bn | 1.07 Bn | - |
| 4 | Encompass Health | 9.72 Bn | 10.34 Bn | 1.34 Bn | - |
| 5 | Ensign | 8.90 Bn | 8.31 Bn | 293.37 Mn | - |
| 6 | Universal Health Services | 8.59 Bn | 8.55 Bn | 3.21 Bn | - |
| 7 | Fresenius Medical Care AG | 7.67 Bn | 5.29 Bn | -4.26 Bn | 45.40 Mn |
| 8 | Chemed | 5.97 Bn | 5.96 Bn | 215.76 Mn | - |
| 9 | Pacs | 5.74 Bn | 5.50 Bn | 345.96 Mn | - |
| 10 | BioCorRx | - | - | 189,355.00 | 352,333.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 352,333.00 |
| Dec 31, 2025 | 1.77 Mn |
| Sep 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 296,860.00 |
| Mar 31, 2025 | 161,919.00 |
| Dec 31, 2024 | 272,543.00 |
| Sep 30, 2024 | 460,138.00 |
| Jun 30, 2024 | 536,362.00 |
| Mar 31, 2024 | 213,834.00 |
| Dec 31, 2023 | 128,295.00 |
| Sep 30, 2023 | 286,962.00 |
| Jun 30, 2023 | 238,419.00 |
| Mar 31, 2023 | 237,387.00 |
| Dec 31, 2022 | 536,104.00 |
| Sep 30, 2022 | 342,553.00 |
| Jun 30, 2022 | 382,952.00 |
| Mar 31, 2022 | 197,849.00 |
| Dec 31, 2021 | 234,423.00 |
| Sep 30, 2021 | 589,985.00 |
| Jun 30, 2021 | 123,262.00 |